» Articles » PMID: 17555573

'I Just Keep Thinking I Haven't Got It Because I'm Not Yellow': a Qualitative Study of the Factors That Influence the Uptake of Hepatitis C Testing by Prisoners

Overview
Publisher Biomed Central
Specialty Public Health
Date 2007 Jun 9
PMID 17555573
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Hepatitis C viral (HCV) infection is a significant public health problem. In the UK, an estimated 200,000 individuals have active HCV infection, most of whom are injecting drug users (IDUs). Many IDUs spend time within the prison system therefore screening for HCV infection in this setting is important. However, uptake of testing within prisons is very low.

Methods: Qualitative interview study. 30 interviews with 25 male and 5 female prisoners with a history of injecting drug use.

Results: Personal and institutional barriers to uptake of testing for HCV were identified. Personal barriers included: prisoners' fears and lack of knowledge about HCV, low motivation for testing, lack of awareness about the testing procedure, and concerns about confidentiality and stigma. Institutional barriers included: the prisons' applications procedure for testing, inadequate pre- and post-test discussion, lack of pro-active approaches to offering testing, and lack of continuity of care on discharge and transfer.

Conclusion: This study highlights potential areas of development in the management of HCV in prisons. Further research is needed to evaluate care pathways for HCV in the prison setting and to develop and assess interventions to improve the uptake of testing for HCV by prisoners.

Citing Articles

Understanding Perceptions of Hepatitis C and Its Management Among People with Experience of Incarceration in Quebec, Canada: A Qualitative Study Guided by the Common Sense Self-Regulation Model.

Mambro A, Mortazhejri S, Ortiz-Paredes D, Patey A, Fontaine G, Dussault C Viruses. 2025; 16(12.

PMID: 39772217 PMC: 11680397. DOI: 10.3390/v16121910.


A Qualitative Systematic Review of Barriers and Facilitators to Hepatitis B and C Programmes in Prisons.

Emery H, Evans C, Jack K, Martello E, Seripenah P, Aiyelabegan F J Viral Hepat. 2024; 32(2):e14049.

PMID: 39731473 PMC: 11681497. DOI: 10.1111/jvh.14049.


Patients' experience of accessing hepatitis C treatment through the Myanmar national hepatitis C treatment program: a qualitative evaluation.

Draper B, Yee W, Bowring A, Naing W, Kyi K, Htay H BMC Health Serv Res. 2024; 24(1):80.

PMID: 38229074 PMC: 10792827. DOI: 10.1186/s12913-023-10456-0.


Disparities in hepatitis C care across Canadian provincial prisons: Implications for hepatitis C micro-elimination.

Kronfli N, Dussault C, Bartlett S, Fuchs D, Kaita K, Harland K Can Liver J. 2022; 4(3):292-310.

PMID: 35992251 PMC: 9202774. DOI: 10.3138/canlivj-2020-0035.


"I'm not gonna be able to do anything about it, then what's the point?": A broad group of stakeholders identify barriers and facilitators to HCV testing in a Massachusetts jail.

Wurcel A, Reyes J, Zubiago J, Koutoujian P, Burke D, Knox T PLoS One. 2021; 16(5):e0250901.

PMID: 34038430 PMC: 8153419. DOI: 10.1371/journal.pone.0250901.


References
1.
Sutton A, Edmunds W, Gill O . Estimating the cost-effectiveness of detecting cases of chronic hepatitis C infection on reception into prison. BMC Public Health. 2006; 6:170. PMC: 1543636. DOI: 10.1186/1471-2458-6-170. View

2.
Rhodes T, Davis M, Judd A . Hepatitis C and its risk management among drug injectors in London: renewing harm reduction in the context of uncertainty. Addiction. 2004; 99(5):621-33. DOI: 10.1111/j.1360-0443.2004.00692.x. View

3.
Heathcote E . Prevention of hepatitis C virus-related hepatocellular carcinoma. Gastroenterology. 2004; 127(5 Suppl 1):S294-302. DOI: 10.1053/j.gastro.2004.09.044. View

4.
Stein K, Dalziel K, Walker A, McIntyre L, Jenkins B, Horne J . Screening for hepatitis C among injecting drug users and in genitourinary medicine clinics: systematic reviews of effectiveness, modelling study and national survey of current practice. Health Technol Assess. 2003; 6(31):1-122. View

5.
Skipper C, Guy J, Parkes J, Roderick P, Rosenberg W . Evaluation of a prison outreach clinic for the diagnosis and prevention of hepatitis C: implications for the national strategy. Gut. 2003; 52(10):1500-4. PMC: 1773842. DOI: 10.1136/gut.52.10.1500. View